Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma.

about

Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma.

Item

http://www.wikidata.org/entity/Q36347277

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma.

@ast

Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma.

@en

type

Item

label

Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma.

@ast

Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma.

@en

prefLabel

Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma.

@ast

Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma.

@en

P1476

Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma

@en

P2093

Alexandra Snyder

http://www.w3.org/2001/XMLSchema#string

Ali Haydar

http://www.w3.org/2001/XMLSchema#string

Ali Shamseddine

http://www.w3.org/2001/XMLSchema#string

Ashwaq El-Olayan

http://www.w3.org/2001/XMLSchema#string

David P Kelsen

http://www.w3.org/2001/XMLSchema#string

Eileen M O'Reilly

http://www.w3.org/2001/XMLSchema#string

Fadi El-Merhi

http://www.w3.org/2001/XMLSchema#string

Ghassan K Abou-Alfa

http://www.w3.org/2001/XMLSchema#string

Leonard B Saltz

http://www.w3.org/2001/XMLSchema#string

Mohamed Eloubeidi

http://www.w3.org/2001/XMLSchema#string

P2860

Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene

Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Importance of age of onset in pancreatic cancer kindreds

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative exploration

Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer.

A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.

Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis.

Cancer risks in BRCA2 mutation carriers.

P304

169-173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23112885

http://www.w3.org/2001/XMLSchema#string

P932

3481149

http://www.w3.org/2001/XMLSchema#string